Drugs Health

Retatrutide trial shows 30% body weight loss, rivalling bariatric surgery results

HQ Team June 17, 2026: Retatrutide, an experimental “triple-agonist” weight-loss drug developed by Eli Lilly, helped patients lose nearly a third of their.

Read More